ArticleLiver international : official journal of the International Association for the Study of the Liver2010
Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.
Article in Liver international : official journal of the International Association for the Study of the Liver, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis.Journal of the renin-angiotensin-aldosterone system : JRAASPooled it
- The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.Digestive diseases and sciences · 2011Trial
- Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2017Article
- Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Digestive diseases and sciences · 2016Review
- Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?World journal of gastroenterology · 2014Review
- Role of NADPH oxidases in liver fibrosis.Antioxidants & redox signaling · 2014Review
- Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment.World journal of hepatology · 2012Article
- Current status of novel antifibrotic therapies in patients with chronic liver disease.Therapeutic advances in gastroenterology · 2011Article
Corrections and comments
- Comment on
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
19515217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.